| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |